World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
73
Citations
22507
World Ranking
2115
National Ranking
186

Mala K. Maini publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mala K. Maini sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 257 publications — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mala K. Maini D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mala K. Maini sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 73 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Mala K. Maini is affiliated with University College London in the United Kingdom. Their research spans multiple fields within medicine, with a strong emphasis on immunology and microbiology. Maini's work focuses extensively on infectious diseases, immunology, epidemiology, and hepatology, contributing insights toward understanding immune cell function and interaction as well as liver disease diagnosis and treatment.

Their primary fields of study include:

  • Medicine
  • Immunology and Microbiology

Key subfields of Maini's research encompass:

  • Immunology
  • Infectious Diseases
  • Epidemiology
  • Hepatology
  • Molecular Biology

Main research topics covered by Maini include:

  • SARS-CoV-2 and COVID-19 Research
  • Hepatitis B Virus Studies
  • Immune Cell Function and Interaction
  • COVID-19 Clinical Research Studies
  • Hepatitis C virus research
  • Immunotherapy and Immune Responses
  • Liver Disease Diagnosis and Treatment

Maini has published in several recurrent scientific venues, including:

  • Journal of Hepatology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • JHEP Reports
  • Science

Frequent coauthors collaborating with Maini are:

  • Laura J. Pallett
  • Leo Swadling
  • Mahdad Noursadeghi
  • Mariana O. Diniz
  • Charlotte Manisty

Recent publications include:

  • Immunotherapies for hepatocellular carcinoma, 2021, Nature Reviews Clinical Oncology
  • Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose, 2021, Science
  • Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure, 2022, Science
  • Sestrins induce natural killer function in senescent-like CD8+ T cells, 2020, Nature Immunology
  • Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection, 2020, Science Immunology

Maini has been recognized as a Fellow of The Academy of Medical Sciences in the United Kingdom.

Best Publications

  • Immunotherapies for hepatocellular carcinoma.

    Josep M Llovet;Josep M Llovet;Josep M Llovet;Florian Castet;Mathias Heikenwalder;Mala K Maini

  • The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection.

    Mala K. Maini;Carolina Boni;Chun Kyon Lee;Juan R. Larrubia

  • Living in the liver: hepatic infections

    Ulrike Protzer;Mala K. Maini;Percy A. Knolle

  • Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms

    George J.M. Webster;Stephanie Reignat;Mala K. Maini;Simon A. Whalley

  • Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)

    Unknown

  • Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure

    Unknown

  • Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage

    Claire Dunn;R. Maurizia Brunetto;Gary Reynolds;Theodoros Christophides

  • Direct ex vivo analysis of hepatitis B virus-specific CD8+ T cells associated with the control of infection

    Mala K. Maini;Carolina Boni;Graham S. Ogg;Abigail S. King

  • A global scientific strategy to cure hepatitis B

    Peter A Revill;Francis V Chisari;Joan M Block;Maura Dandri

  • Modulation of the CD8+-T-Cell Response by CD4+ CD25+ Regulatory T Cells in Patients with Hepatitis B Virus Infection

    Ornella Franzese;Patrick T. F. Kennedy;Adam J. Gehring;Jim Gotto

  • Temporal analysis of early immune responses in patients with acute hepatitis B virus infection.

    Claire Dunn;Dimitra Peppa;Pooja Khanna;Gaia Nebbia

  • IL-10–Producing Regulatory B Cells in the Pathogenesis of Chronic Hepatitis B Virus Infection

    Abhishek Das;Gidon Ellis;Celeste Pallant;A. Ross Lopes

  • Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell–mediated deletion

    Dimitra Peppa;Upkar S. Gill;Gary Reynolds;Nicholas J.W. Easom

  • Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.

    Leo Swadling;Mariana O. Diniz;Nathalie M. Schmidt;Oliver E. Amin

  • Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection.

    Anna Schurich;Pooja Khanna;A. Ross Lopes;Ki Jun Han

  • IL-2high tissue-resident T cells in the human liver: Sentinels for hepatotropic infection.

    Laura J. Pallett;Jessica Davies;Emily J. Colbeck;Francis Robertson

  • Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose.

    Catherine J. Reynolds;Corinna Pade;Joseph M. Gibbons;David K. Butler

  • Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡

    Markus Cornberg;Anna Suk Fong Lok;Norah A. Terrault;Fabien Zoulim

  • Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection.

    Gaia Nebbia;Dimitra Peppa;Anna Schurich;Pooja Khanna

  • Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?

    Antonio Bertoletti;Mala K Maini

  • Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection

    Stephanie Reignat;George J.M. Webster;David Brown;Graham S. Ogg

  • Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection.

    Abhishek Das;Matthew Hoare;Nathan A. Davies;A. Ross Lopes

  • The role of virus-specific CD8+cells in liver damage and viral control during persistent hepatitis B virus infection

    M K Maini;C Boni;K Lee;Larrubia

Frequent Co-Authors

Antonio Bertoletti
Antonio Bertoletti Duke NUS Graduate Medical School
Richard Gilson
Richard Gilson University College London
Graham S. Ogg
Graham S. Ogg University of Oxford
James C. Moon
James C. Moon University College London
Brian R. Davidson
Brian R. Davidson University College London
Graham R. Foster
Graham R. Foster Queen Mary University of London
Hans J. Stauss
Hans J. Stauss University College London
Roger Williams
Roger Williams Foundation for Liver Research
Carlo Ferrari
Carlo Ferrari University of Parma
Diego Vergani
Diego Vergani King's College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related online degrees can open diverse career opportunities in healthcare and research. Many students from non-clinical backgrounds consider enrolling in online adn programs for non nurses to gain foundational nursing skills. These programs provide a pathway to enter clinical roles while complementing immunology expertise.

Accelerated programs are also popular for individuals aiming to transition quickly into nursing careers. The easiest absn programs to get into offer expedited curricula designed to help students earn a Bachelor of Science in Nursing efficiently—ideal for those with prior degrees who want to enter immunology-related healthcare roles.

For entry-level nursing roles, easy lpn programs to get into provide accessible options to start working in patient care, which often intersects with immunology fields in clinical settings. These programs serve as stepping stones toward more advanced immunology and healthcare careers.

Finally, advanced practice roles such as nurse practitioners offer specialized opportunities to apply immunology knowledge in patient diagnosis, treatment, and research. The easiest nurse practitioner degree programs allow graduates to enhance their clinical expertise and contribute significantly to immunology-related healthcare services.

Best Scientists Citing Mala K. Maini

Trending Scientists

Recently Published Articles